Log in to search using one of your social media accounts:

 

Children ’ s deaths from flu rise sharply amid signs that season may be hitting plateau
This file has been updated. Flu has killed 22 more children, the most reported since the respiratory virus began slamming the country in the fall, according to a government report released Friday. The total number of flu-related pediatric deaths is now at least 84 nationwide. But other indicators from the Centers for Disease Control and Prevention suggest […]Related:Here’s what you should know about the flu season this yearThis season’s flu vaccine is only 36 percent effective, but experts say you should still get itNine organizations sue Trump administration for ending grants to teen pregnancy...
Source: Washington Post: To Your Health - February 16, 2018 Category: Consumer Health News Source Type: news

Long - Term Inhaled Corticosteroid Use May Raise Fracture Risk
Long - term inhaled corticosteroid use for COPD tied to small increased risk of hip, upper extremity fracture (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - February 16, 2018 Category: Respiratory Medicine Tags: Internal Medicine, Orthopedics, Pharmacy, Pulmonology, Journal, Source Type: news

Influenza A(H3N2) Viruses Predominate 2017 - 2018 Season
Vaccine effectiveness estimated at 25 percent against A(H3N2) (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - February 16, 2018 Category: Respiratory Medicine Tags: Family Medicine, Geriatrics, Gynecology, Infections, Internal Medicine, Critical Care, Emergency Medicine, Nursing, Pathology, Pediatrics, Pharmacy, Pulmonology, Journal, Source Type: news

Children ’s deaths from flu climb sharply, CDC reports
Flu has killed 22 more children, the most reported since the respiratory virus began slamming the country in the fall, according to a government report released Friday. The total number of flu-related child deaths is now at least 84. But other indicators from the Centers for Disease Control and Prevention suggest that this vicious influenza season […]Related:Here’s what you should know about the flu season this yearThis season’s flu vaccine is only 36 percent effective, but experts say you should still get itNine organizations sue Trump administration for ending grants to teen pregnancy programs (So...
Source: Washington Post: To Your Health - February 16, 2018 Category: Consumer Health News Source Type: news

How humans regulate Aspergillus colonization in fungal allergy
Friday, February 16, 2018 - 15:37Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 16, 2018 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Genetics of Aspergillosis
Friday, February 16, 2018 - 15:35Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 16, 2018 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Nurses who clean the most may be at respiratory risk
Women who regularly use cleaning sprays or other cleaning products at work appear to experience a greater decline in lung function over time than women who do not, according to new research. (Source: Nursing Times)
Source: Nursing Times - February 16, 2018 Category: Nursing Source Type: news

Women who clean at home or work face increased lung function decline
(American Thoracic Society) Women who work as cleaners or regularly use cleaning sprays or other cleaning products at home appear to experience a greater decline in lung function over time than women who do not clean, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 16, 2018 Category: International Medicine & Public Health Source Type: news

Aspergillus Immunology and Inflammation
Thursday, February 15, 2018 - 10:52Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 15, 2018 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Why and when aspergillosis first appears in cystic fibrosis patients?
Thursday, February 15, 2018 - 10:48Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 15, 2018 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Fungus-specific CD4 T Cells as Specific Sensors for Pulmonary Fungal Infections & Sensitization
Fungus-specific CD4 T Cells as Specific Sensors for Pulmonary Fungal Infections& SensitizationThursday, February 15, 2018 - 10:46Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 15, 2018 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Occupational exposures and diseases
Thursday, February 15, 2018 - 10:34Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 15, 2018 Category: Respiratory Medicine Authors: ROrritt Source Type: news

The Human Lung and Aspergillosis: You are what you Breathe in?
Thursday, February 15, 2018 - 10:30Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 15, 2018 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Managing breakthrough invasive aspergillosis
Thursday, February 15, 2018 - 10:19Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 15, 2018 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Recent Advances in Diagnosis and Treatment of Allergic Aspergillosis
Thursday, February 15, 2018 - 10:18Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 15, 2018 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Mechanisms of non-CYP51 azole resistance
Thursday, February 15, 2018 - 10:00Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 15, 2018 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Why are NK cells important for defense against Aspergillus
Thursday, February 15, 2018 - 09:57Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 15, 2018 Category: Respiratory Medicine Authors: ROrritt Source Type: news

How to Make a Fast Diagnosis
Thursday, February 15, 2018 - 09:56Slide presentation (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 15, 2018 Category: Respiratory Medicine Authors: ROrritt Source Type: news

GSK seeks expanded label for Trelegy Ellipta inhaler in EU
GlaxoSmithKline (NYSE:GSK) and Innoviva (NSDQ:INVA) have submitted data to the European Medicines Agency in the hopes of expanding the label for its once-daily, triple combination inhaler, Trelegy Ellipta. The drug-device combo was approved in Europe in November last year as a maintenance treatment for adult patients with moderate to severe chronic obstructive pulmonary disease who are not adequately treated by a inhaled corticosteroid combined with a long-acting beta-adrenergic agonist. GSK and Innoviva hope that data from its Impact trial will support the product’s use in a broader populati...
Source: Mass Device - February 14, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Pharmaceuticals Respiratory Wall Street Beat GlaxoSmithKline plc Innoviva Source Type: news

Morning Break:'20 Years Late'; Drugs in the Dirt; Catching Flu in the Dorm
(MedPage Today) -- Health news and commentary from around the Web gathered by the MedPage Today staff (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - February 14, 2018 Category: Respiratory Medicine Source Type: news

Self-rated health and respiratory symptoms among civil aviation pilots : Occupational and non-occupational risk factors
2017Reference type: ThesisPost date: Wednesday, February 14, 2018 - 11:55Books and theses (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 14, 2018 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Health Tip: Living with Pulmonary Fibrosis
Title: Health Tip: Living with Pulmonary FibrosisCategory: Health NewsCreated: 2/14/2018 12:00:00 AMLast Editorial Review: 2/14/2018 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - February 14, 2018 Category: Respiratory Medicine Source Type: news

Widely Used COPD Meds Tied to Increased Fracture Risk
Title: Widely Used COPD Meds Tied to Increased Fracture RiskCategory: Health NewsCreated: 2/13/2018 12:00:00 AMLast Editorial Review: 2/14/2018 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - February 14, 2018 Category: Respiratory Medicine Source Type: news

Asthma Doesn't Have to Ruin Your Valentine's Day
Title: Asthma Doesn't Have to Ruin Your Valentine's DayCategory: Health NewsCreated: 2/14/2018 12:00:00 AMLast Editorial Review: 2/14/2018 12:00:00 AM (Source: MedicineNet Asthma General)
Source: MedicineNet Asthma General - February 14, 2018 Category: Respiratory Medicine Source Type: news

NIH study will assess biomarker as potential indicator of whether lower respiratory tract infections improve with antibacterial treatment
LRTIs can cause a variety of symptoms, including persistent coughing, wheezing, chest pain, fever, and rapid or difficult breathing. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - February 13, 2018 Category: American Health Source Type: news

Considerations for the Use of Temporary Surge Sites for Managing Seasonal Patient Surge
U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response. 02/12/2018 This 18-page document from TRACIE (Technical Resources, Assistance Center, and Information Exchange) describes the major considerations healthcare facility emergency planners must consider when determining patient surge management solutions for longer-duration events, such as weeks to months of managing seasonal illness surge. During the severe 2017-2018 influenza season, coupled with increases in other upper respiratory infections, many hospitals have surpassed routine surge management measures and hav...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - February 13, 2018 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Widely Used COPD Meds Tied to Increased Fracture Risk
(Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - February 13, 2018 Category: Respiratory Medicine Tags: Orthopedics, Pulmonology, Rheumatology, Geriatrics, News, Source Type: news

Nurses asked for views to help build respiratory health strategy
A new “taskforce for lung health”, comprising 25 representatives from the respiratory sector, is calling for evidence to identify what needs to change in the prevention and diagnosis of lung disease. (Source: Nursing Times)
Source: Nursing Times - February 13, 2018 Category: Nursing Source Type: news

Another Downside to Opioid Use: Pneumonia?
Title: Another Downside to Opioid Use: Pneumonia?Category: Health NewsCreated: 2/12/2018 12:00:00 AMLast Editorial Review: 2/13/2018 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - February 13, 2018 Category: Respiratory Medicine Source Type: news

NIH study will assess biomarker as indicator of viral lower respiratory tract infection
(NIH/National Institute of Allergy and Infectious Diseases) A new clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, aims to determine whether low blood levels of the protein procalcitonin can reliably indicate whether a person's lower respiratory tract infection will improve with antibiotic treatment. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 13, 2018 Category: Infectious Diseases Source Type: news

EHRs Not Sufficient to Ensure Success in Value - Based Care
EHRs do not necessarily capture information needed; interoperability is poor, analytics are incomplete (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - February 13, 2018 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Another Downside to Opioid Use: Pneumonia?
(Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - February 12, 2018 Category: Respiratory Medicine Tags: Infections, Pharmacy, Pulmonology, News, Source Type: news

Think Extermination Ends Your Bedbug Woes? Think Again
(Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - February 12, 2018 Category: Respiratory Medicine Tags: Dermatology, Nursing, Pulmonology, News, Source Type: news

Inhaled Nitric Oxide Unhelpful for Very Premature Newborns in Respiratory Distress Inhaled Nitric Oxide Unhelpful for Very Premature Newborns in Respiratory Distress
Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 12, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Pulmatrix doses first patient in Ph1 Pulmazole trial
Pulmatrix (NSDQ:PULM) said today that the first patient was treated in a first-in-human study of Pulmazole – an inhaled formulation of the anti-fungal drug, itraconazole. The Lexington, Mass.-based company is evaluating its iSperse formulation of the drug as a treatment for asthma patients who have developed allergic bronchopulmonary aspergillosis. Get the full story at our sister site, Drug Delivery Business News. The post Pulmatrix doses first patient in Ph1 Pulmazole trial appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 12, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Pharmaceuticals Respiratory Wall Street Beat Pulmatrix Inc. Source Type: news

Teva launches breath-activated asthma aerosol in U.S.
Teva Pharmaceuticals (NYSE:TEVA) has launched its Qvar RediHaler inhalation aerosol in the U.S., marking the first time a breath-actuated inhaled corticosteroid is available for asthma patients as a prophylactic therapy. In contrast to traditional metered-dose inhalers, Teva’s Qvar RediHaler sends medication into the user’s lungs as they inhale. This feature eliminates the need for hand-breath coordination, according to Teva. Get the full story at our sister site, Drug Delivery Business News. The post Teva launches breath-activated asthma aerosol in U.S. appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 12, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Pharmaceuticals Respiratory Wall Street Beat Teva Pharmaceuticals Source Type: news

Asbestos (Exposure Dangers, Testing, Symptoms)
Title: Asbestos (Exposure Dangers, Testing, Symptoms)Category: Diseases and ConditionsCreated: 2/21/2000 12:00:00 AMLast Editorial Review: 2/12/2018 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - February 12, 2018 Category: Respiratory Medicine Source Type: news

East Africa:What's Likely to Kill You? Respiratory, Heart Diseases
[East African] Health experts are sounding the alarm over non-communicable diseases, which now top the list of the region's killers. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 12, 2018 Category: African Health Source Type: news

What Growth Charts Are Best?
Discussion “The value of growth assessment is thus its principal utility as a key screening tool in order to assess children’s general well-being, to identify faltering and excessive growth, to evaluate maternal lactation performance and infant feeding practices, and to manage her children with medical conditions known to adversely affect growth,….” Thus having assessment tools is important. Growth charts are assessment tools measuring height/length, weight, head circumference and body mass index. Some commonly used growth charts are: WHO child growth chart standards They were developed using lo...
Source: PediatricEducation.org - February 12, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Medical News Today: Are there any home remedies for pneumonia?
A look a home remedies for pneumonia, a disorder with some symptoms you can manage at home. Included is detail on prevention and when to see a doctor. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 11, 2018 Category: Consumer Health News Tags: Respiratory Source Type: news

2018 Annual Review of the Blueprint List of Priority Diseases
World Health Organization. 02/08/2018 This Web page provides the 2018 List of Priority Diseases, which include Ebola virus disease and Marburg virus disease, Lassa fever, Middle East respiratory syndrome coronavirus (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS), and Zika virus. Experts consider that given their potential to cause a public health emergency and the absence of efficacious drugs and/or vaccines, there is an urgent need for accelerated research and development for these diseases. (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - February 10, 2018 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Injury Scene Characteristics Linked to Injury Mortality
Increased odds of death for patients injured at locations farthest from level 1 or 2 trauma centers (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - February 10, 2018 Category: Respiratory Medicine Tags: Pulmonology, Surgery, Critical Care, Emergency Medicine, Journal, Source Type: news

Students with 9/11-related illnesses describe diagnoses
Former students of a high school that was engulfed in toxins after the Twin Towers exploded blocks away are being sickened by respiratory diseases and cancer more than 15 years after the attacks. (Source: the Mail online | Health)
Source: the Mail online | Health - February 9, 2018 Category: Consumer Health News Source Type: news

N8 Medical submits IDE app seeking 1st-in-human trial of CeraShield endotracheal tube
N8 Medical said today it submitted an investigational device exemption application to the FDA for a first-in-human study of its CeraShield endotracheal tube. The Dublin, Ohio-based company’s CeraShield ETT is a ceragenin-coated ETT designed to prevent the growth of biofilms and reduce potential for infection for intubated patients. “We are looking forward to bringing our breakthrough CeraShield endotracheal tube device to patients and hospitals that we believe will realize a substantial benefit,” prez & COO Ronald Bracken said in prepared remarks. N8 said it is hopeful it will be able to initiate huma...
Source: Mass Device - February 9, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Food & Drug Administration (FDA) Respiratory n8medical Source Type: news

Innoviva posts Street-beating Q4, FY17 earnings
Shares in Innoviva (NSDQ:INVA) rose today after the company topped expectations on Wall Street with its fourth quarter and full-year financial results. The Brisbane, Calif.-based company posted profits of $58.4 million, or 55¢ per share, on sales of $69.5 million for the 3 months ended Dec. 31, for bottom-line growth of 129% on sales growth of 59% compared with the same period last year. Get the full story at our sister site, Drug Delivery Business News. The post Innoviva posts Street-beating Q4, FY17 earnings appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 9, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations MassDevice Earnings Roundup Pharmaceuticals Respiratory Wall Street Beat Innoviva Source Type: news

Respiratory Syncytial Virus Seasonality -- United States Respiratory Syncytial Virus Seasonality -- United States
A new statistical method is being used to more accurately determine respiratory syncytial virus seasonality nationally and by region.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 9, 2018 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news

GlaxoSmithKline Sees Light at End of Advair Tunnel GlaxoSmithKline Sees Light at End of Advair Tunnel
GlaxoSmithKline sees growth strengthening over the next few years as the drugmaker weathers increased competition in its core respiratory and HIV businesses that could cause earnings to dip this year.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 8, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

FDA rejects Novartis ’ Advair generic, leaving GSK without rival
GlaxoSmithKline (NYSE:GSK) was granted a temporary win today after Novartis‘ (NYSE:NVS) Sandoz unit reported that the FDA rejected its application for a generic version of the company’s blockbuster lung treatment, Advair. The regulatory agency reportedly told Novartis that it needs to submit additional clinical data before the FDA can make its final decision. Get the full story at our sister site, Drug Delivery Business News. The post FDA rejects Novartis’ Advair generic, leaving GSK without rival appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 8, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Pharmaceuticals Regulatory/Compliance Respiratory Wall Street Beat GlaxoSmithKline plc Novartis sandoz Source Type: news

Preventing Vasospasm in Aneurysmal Subarachnoid Hemorrhage Preventing Vasospasm in Aneurysmal Subarachnoid Hemorrhage
Which strategies may help prevent cerebral vasospasm among ICU patients with aneurysmal subarachnoid hemorrhage?Seminars in Respiratory and Critical Care Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 8, 2018 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news

GlaxoSmithKline sees light at end of Advair tunnel
LONDON (Reuters) - GlaxoSmithKline sees growth strengthening over the next few years as the drugmaker weathers increased competition in its core respiratory and HIV businesses that could cause earnings to dip this year. (Source: Reuters: Health)
Source: Reuters: Health - February 7, 2018 Category: Consumer Health News Tags: healthNews Source Type: news